Paget's disease of bone: Difference between revisions

Line 21: Line 21:


==Evaluation==
==Evaluation==
[[File:Paget's disease R coxal.jpg|thumb|Paget's disease of right innominate bone.]]
*Imaging to evaluate for [[fractures]]
*Imaging to evaluate for [[fractures]]
**Initial lesion may be destructive, radiolucent (especially in skull)
**Initial lesion may be destructive, radiolucent (especially in skull)

Revision as of 03:25, 11 December 2019

Background

  • Characterized by areas of bone with excessive osteolytic activity and subsequent increased ostoblastic activity, resulting in disorganized bone formation
  • Results in osteolytic lesions and weakened bone
  • Eventually, affected bones may be abnormally enlarged
  • Exact etiology unknown, likely genetic component
  • Prevalence increases with age, more common in people of European descent

Clinical Features

  • Initially asymptomatic or mild pain
  • Bone pain at affected sites, often worse at night
  • Pathologic fractures
  • If skull involved, may report increased hat size, headache, decreased hearing

Differential Diagnosis


Bone tumors and their mimics

Malignant


Benign


Other

Evaluation

Paget's disease of right innominate bone.
  • Imaging to evaluate for fractures
    • Initial lesion may be destructive, radiolucent (especially in skull)
    • Involved bones may be expanded, abnormally dense
    • May have multiple fissure fractures in long bones
  • Alk phos typically very high
  • Serum calcium may be high

Management

  • Treat fractures
  • Pain control
  • Bisphosphonates (e.g. Zoledronate) are treatment of choice for patients with severe symptoms or advanced disease

Disposition

  • Discharge uncomplicated patients

See Also

External Links

References